SAN JOSE, Calif. – (Business Wire) DFine, Inc., developer of minimally invasive solutions for treating vertebral pathologies, announced today the signing of two distribution agreements. Siad Healthcare and Reflexion Pharma will represent DFine’s StabiliT® Vertebral Augmentation System in Italy and Morocco, respectively. Expansion into four additional countries within Europe and the Middle East are scheduled in the second half of 2010. More »
SAN JOSE, Calif.–(HSMN NewsFeed)–DFine, Inc., a developer of minimally invasive solutions for treating vertebral pathologies, announced today the appointment of James M. (Jim) Mazzarella to the position of Vice President of Sales. Jim brings to DFine over 25 years of high level sales and marketing experience in the medical device industry. He began his career at Johnson & Johnson, where he assumed increasingly greater levels of responsibility in sales management and marketing during his 20 years with the company, eventually directing the launch of the now market-leading STERRAD® low temperature sterilization system at Advanced Sterilization Products, a division of Ethicon. Jim also held senior leadership roles at Medpool.com and TSO3, Inc. More »
SAN JOSE, Calif.–(HSMN NewsFeed)–DFine, Inc., a developer of minimally invasive solutions for treating vertebral compression fractures, announced today that it has launched a next generation access system for the RF Kyphoplasty procedure using the StabiliT® Vertebral Augmentation System. More »
| Nuvasive, Inc. | 30.75 | ||
| Zimmer Holdings, | 48.95 | ||
| Alphatec Holdings | 2.15 | ||
| Smith & Nephew Sn | 42.35 | ||
| Trans1 Inc. | 2.51 | ||
| Medtronic Inc. Co | 32.71 | ||
| Synthes | 119.90 | ||
| Rti Biologics, In | 2.20 | ||
| Johnson & Johnson | 59.82 | ||
| Orthofix Internat | 29.06 | ||
| Covidien Plc. Ord | 36.70 | ||
| Orthovita, Inc. | 1.72 | ||
| Integra Lifescien | 37.50 |
Archive for Publications »
